Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study has been conceived in the context of Health Outcomes Research where the outcomes of health interventions in routine clinical practice constitute the main objective of the research process. In the case of asthma in Spain, the investigators do not clearly know the use of resources generated by the patient with asthma, its impact on the effectiveness of the current approach of asthmatic patients and the overall efficiency of health interventions on asthmatic patients. This observational, retrospective and multicenter study aims to estimate the use of health care resources in managing patients with asthma and to determine the management of the disease in the usual clinical practice in Valencia Autonomous Region. The data will be obtained at primary care level from the Electronic Health Record SIA+GAIA data base and at hospital level from allergologists and pneumologists clinical records. The investigators plan to introduce 289 ambulatory patients followed-up in Primary or Specialized Care Services, older than 15 years of age, diagnosed of asthma at least one year before the beginning of the study. The inclusion period will be of 3 months and the retrospective data of 12 previous months of follow-up will be collected.
The direct and indirect use of resources will be collected in order to estimate the management and use of health care resources in managing patients with asthma in the Autonomous region of Valencia as primary endpoint and also to estimate the mean cost of asthmatic patient healthcare; to determine the global effectiveness and the efficiency of the actual asthmatic patient healthcare and to model the health budget according to different objectives of effectiveness for the next five years.
| Condition |
|---|
|
Asthma Valencia Autonomous Region |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia |
- Direct and indirect Resource Use of Asthma patients in 12 months [ Time Frame: Once the patient has been included data refered to the previous 12 month following-up period will be recorded. Thus, all data will be recorded at that time-period. Only one data recording will be done. ] [ Designated as safety issue: No ]
| Enrollment: | 292 |
| Study Start Date: | September 2010 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 15 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Ambulatory patients followed-up in Primary or Specialized Care Services (hospital)
Inclusion Criteria:
- Ambulatory patients (Primary and Specialized Care)
- Patients with a diagnose of asthma in the Outpatients' Electronic Health Record [Historia Clínica Ambulatoria electrónica (SIA + GAIA) database
Exclusion Criteria:
- Patients who have participated in a clinical trial in the last 12 months.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT01114906 History of Changes |
| Other Study ID Numbers: | NIS-RES-DUM-2010/1 |
| Study First Received: | April 20, 2010 |
| Last Updated: | September 16, 2011 |
| Health Authority: | Spain: Ethics Committee |
Keywords provided by AstraZeneca:
|
Asthma Resource use |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013